Boehringer Ingelheim kicked off construction on a new 285 million euro ($315 million) plant at its German headquarters that will produce active pharmaceutical ingredients and drugs for clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,